104 related articles for article (PubMed ID: 30654807)
1. Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma with skull-base invasion after intensity-modulated radiotherapy.
Feng Y; Cao C; Hu Q; Chen X
Radiat Oncol; 2019 Jan; 14(1):10. PubMed ID: 30654807
[TBL] [Abstract][Full Text] [Related]
2. MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.
Cheng YK; Liu LZ; Jiang N; Yue D; Tang LL; Zhang F; Lin L; Liu X; Chen L; Ma J
Strahlenther Onkol; 2014 Oct; 190(10):905-11. PubMed ID: 24763663
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
Hung TM; Chen CC; Lin CY; Ng SH; Kang CJ; Huang SF; Liao CT; Fan KH; Wang HM; Chang JT
Oral Oncol; 2014 Mar; 50(3):228-33. PubMed ID: 24394562
[TBL] [Abstract][Full Text] [Related]
4. Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
Cao C; Jiang F; Jin Q; Jin T; Huang S; Hu Q; Chen Y; Piao Y; Hua Y; Feng X; Chen X
Cancer Res Treat; 2019 Jan; 51(1):73-79. PubMed ID: 29510615
[TBL] [Abstract][Full Text] [Related]
5. Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
Liao S; Xie Y; Feng Y; Zhou Y; Pan Y; Fan J; Mi J; Qin X; Yao D; Jiang W
J Cancer Res Clin Oncol; 2020 Feb; 146(2):429-439. PubMed ID: 31677113
[TBL] [Abstract][Full Text] [Related]
6. Subclassification of skull-base invasion for nasopharyngeal carcinoma using cluster, network and survival analyses: A double-center retrospective investigation.
Li HJ; Hu YY; Huang L; Zhou J; Li JJ; Xie CB; Chen MY; Sun Y; Liu LZ; Tian L
Radiother Oncol; 2019 May; 134():37-43. PubMed ID: 31005222
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
Zhou GQ; Mao YP; Chen L; Li WF; Liu LZ; Sun Y; Chen Y; Tian L; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1090-7. PubMed ID: 21864993
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
10. Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
Xue F; Ou D; Ou X; Zhou X; Hu C; He X
Oral Oncol; 2020 Jan; 100():104478. PubMed ID: 31759331
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
[TBL] [Abstract][Full Text] [Related]
12. Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value.
Chen L; Liu LZ; Mao YP; Tang LL; Sun Y; Chen Y; Lin AH; Li L; Ma J
Head Neck; 2011 Sep; 33(9):1309-14. PubMed ID: 21837701
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging.
Li YZ; Cai PQ; Xie CM; Huang ZL; Zhang GY; Wu YP; Liu LZ; Lu CY; Zhong R; Wu PH
Eur J Radiol; 2013 Mar; 82(3):e107-11. PubMed ID: 23181975
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Cao C; Luo J; Gao L; Yi J; Huang X; Li S; Xiao J; Zhang Z; Xu G
Cancer Res Treat; 2017 Apr; 49(2):518-525. PubMed ID: 27554478
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
16. Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
Wu L; Zhuo S; Zeng W; Liang S; Wang S; Cui C; Zhou J; Ruan G; Xu S; Wang L; Huang L; Liu L; Li H
Head Neck; 2019 Dec; 41(12):4088-4097. PubMed ID: 31518030
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
[TBL] [Abstract][Full Text] [Related]
18. The Value of Tumor Diameter in Predicting Prognosis of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Niu ZJ; Li T; Liang ZG; Chen XQ; Zhao W; Zhu XD
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):305-311. PubMed ID: 28145845
[TBL] [Abstract][Full Text] [Related]
19. Value of skull base invasion subclassification in nasopharyngeal carcinoma: implication for prognostic stratification and use of induction chemotherapy.
Li S; Luo C; Huang W; Zhu S; Ruan G; Liu L; Li H
Eur Radiol; 2022 Nov; 32(11):7767-7777. PubMed ID: 35639144
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
Feng Y; Cao C; Hu Q; Chen X
Cancer Res Treat; 2019 Jul; 51(3):1222-1230. PubMed ID: 30590003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
